Filter Results:
(2,465)
Show Results For
- All HBS Web
(5,158)
- People (16)
- News (1,906)
- Research (2,465)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,883)
Show Results For
- All HBS Web
(5,158)
- People (16)
- News (1,906)
- Research (2,465)
- Events (2)
- Multimedia (221)
- Faculty Publications (1,883)
Sort by
- 13 May 2008
- First Look
First Look: May 13, 2008
community-based health center) are also discussed. Purchase this case: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=308072 Global Climate Change and BP Harvard Business School Case 708-026 Following the sudden... View Details
Keywords: Martha Lagace
- 18 Dec 2018
- First Look
New Research and Ideas, December 18, 2018
together, our results highlight how revealing failures encountered on the way to success can be a counterintuitive yet effective interpersonal emotion regulation strategy. Publisher's link:... View Details
Keywords: Dina Gerdeman
- 15 Aug 2006
- First Look
First Look: August 15, 2006
carburetors. Download working paper: http://www.hbs.edu/research/pdf/07-009.pdf Cases & Course MaterialsInnovating in Health Care—Framework Harvard Business School Note 306-042 Contains the framework for the second-year Innovating... View Details
Keywords: Sean Silverthorne
- August 2024
- Article
How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?
By: Leemore S. Dafny, Kate Ho and Edward Kong
Drug copayment coupons to reduce patient cost-sharing have become nearly ubiquitous for high-priced brand-name prescription drugs. Medicare bans such coupons on the grounds that they are kickbacks that induce utilization, but they are commonly used by... View Details
Keywords: Prescription Drugs; Coupons; Impact; Health Care and Treatment; Markets; Price; Spending; Pharmaceutical Industry; United States
Dafny, Leemore S., Kate Ho, and Edward Kong. "How Do Copayment Coupons Affect Branded Drug Prices and Quantities Purchased?" American Economic Journal: Economic Policy 16, no. 3 (August 2024): 314–346.
- April 2017
- Supplement
Imprimis (B)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A). It describes the company’s decision to enter into the pharmaceutical compounding business in 2013–2014. Imprimis purchased a compounded ophthalmological medication called Dropless Therapy, which was injected into patients’... View Details
Keywords: Healthcare; Drug Compounding; Drug Development; Pharmaceuticals; Small Business; Decision-making, Business Model; Mark Baum; Imprimis; Decision Making; Strategy; Health Care and Treatment; Policy; Pharmaceutical Industry; United States
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (B)." Harvard Business School Supplement 717-496, April 2017.
- August 2013 (Revised October 2013)
- Case
MedImmune Ventures
By: Richard G. Hamermesh and David Lane
Ron Laufer is the new Senior Managing Director of MedImmune Ventures, the corporate venture capital arm of AstraZeneca, a leading pharmaceuticals firm. Laufer has to decide whether to pursue a high-potential, but very risky, early-stage investment. The decision Laufer... View Details
Keywords: MedImmune; MedImmune Ventures; AstraZeneca; NeuProtect; Corporate Venturing; Biotechnology; Venture Investing; Venture Capital; Health Care and Treatment; Pharmaceutical Industry; Financial Services Industry; Biotechnology Industry; United States; Australia; Europe; London
Hamermesh, Richard G., and David Lane. "MedImmune Ventures." Harvard Business School Case 814-023, August 2013. (Revised October 2013.)
- December 2005 (Revised April 2010)
- Teaching Note
Leerink Swann & Co.: Creating Competitive Advantage (TN)
By: Boris Groysberg and Andrew N. McLean
- February 2022
- Case
Leading The UK Vaccine Task Force
By: Amy C. Edmondson and Claudia Pienica
This case describes the first six months of the UK Vaccine Taskforce, under the leadership of Kate Bingham. With a career spent in the private sector as a biotech investor, Bingham’s appointment within the government was considered unusual. The overarching brief given... View Details
Keywords: COVID-19; Vaccine; Government; Health Pandemics; Health Care and Treatment; Science; Innovation and Invention; Groups and Teams; Leadership; Decision Making; Government and Politics; Health; Innovation and Management; Governance; Change; Government Administration; Health Industry; Health Industry; Health Industry; Europe; United Kingdom
Edmondson, Amy C., and Claudia Pienica. "Leading The UK Vaccine Task Force." Harvard Business School Case 622-079, February 2022.
- 28 Apr 2010
- Research & Ideas
Earth Day Reflections
opportunity to engage in a virtual dialogue on these matters. Some major corporations are starting to take the lead in this effort, including United Technologies Corporation, Philips (the Dutch electronics and health View Details
Keywords: by Staff
- 19 Nov 2010
- Research & Ideas
The Landscape of Integrated Reporting: An E-Book
lost trust in business. Whether it be the environment, health care, or making sure that people have access to information, I can't think of any major problem that society confronts today that can be effectively solved unless business... View Details
- 17 Oct 2006
- First Look
First Look: October 17, 2006
find support for these hypotheses. Download working paper: http://www.hbs.edu/research/pdf/07-022.pdf Resolving Information Asymmetries in Markets: The Role of Certified Management Programs Author: Michael W. Toffel Abstract Firms and View Details
Keywords: Sean Silverthorne
- 06 Jan 2012
- Op-Ed
Where Green Corporate Ratings Fail
illustration of this omission, Apple, a US consumer electronics manufacturer, publicly resigned in 2009 from the US Chamber of Commerce, the largest business lobbying group in the country. "Apple supports regulating greenhouse gas... View Details
- 31 May 2016
- First Look
May 31, 2016
June 2016 Medical Care Vaccination Rates Are Associated with Functional Proximity but Not Base Proximity of Vaccination Clinics By: Beshears, John, James J. Choi, David Laibson, Brigitte C. Madrian, and Gwendolyn I. Reynolds... View Details
Keywords: Sean Silverthorne
- 23 Dec 2002
- Research & Ideas
Partnering and the Balanced Scorecard
large operating losses into positive operating margins, while achieving levels of patient care and satisfaction that were ranked best in their category. Having constructed the high-level strategy map and scorecard, leaders cascade the... View Details
Keywords: by Robert S. Kaplan & David P. Norton
- 13 May 2014
- First Look
First Look: May 13
Harvard Business School Case 714-471 Martini Klinik: Prostate Cancer Care Since its establishment in 2005, Hamburg's Martini Klinik had single mindedly focused on prostate cancer care with a commitment to... View Details
Keywords: Sean Silverthorne
- 10 Oct 2007
- First Look
First Look: First Look: October 10
to customize therapy for individuals. However, adoption of this approach has progressed slowly and unevenly because the trial-and-error treatment model still governs how the health care system develops,... View Details
Keywords: Martha Lagace
- 03 Aug 2010
- First Look
First Look: August 3
employees are more likely to speak up and offer solutions when organizations launch information campaigns to promote process improvement and when managers engage in process-improvement activities themselves. We test our hypotheses in the View Details
Keywords: Martha Lagace
- 13 Jan 2009
- First Look
First Look: January 13, 2009
and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70... View Details
Keywords: Martha Lagace
- 03 Dec 2008
- What Do You Think?
Can Housing and Credit be “Nudged” Back to Health?
regulation should be there.... Keeping 'excess' in check is an appropriate response by a civilized society." As Edware Hare put it, "Forget 'nudging.' We need to replace self-indulgence with self-restraint ... better education... View Details
Keywords: by Jim Heskett
- Article
Believe in Vaccine Bets Like Bill Gates's
Commitment of public or private funds upfront speeds development, production, and distribution. View Details
Keywords: Coronavirus; Vaccine; Financing; Health Pandemics; Health Care and Treatment; Product Development; Production; Distribution
Kominers, Scott Duke. "Believe in Vaccine Bets Like Bill Gates's." Bloomberg Opinion (April 28, 2020).